Unknown

Dataset Information

0

Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy.


ABSTRACT:

Background and aims

Monitoring of chronic Hepatitis C (CHC) treatment relies on HCV RNA quantification by means of real-time PCR methods. Assay specific analytical sensitivities may impact therapy management.

Methods

Comparative analysis between three commercial assays (Roche COBAS AmpliPrep/COBAS TaqMan Version 1 (CAP/CTM Ver. 1), Version 2 (CAP/CTM Ver. 2) and the Abbott RealTime HCV (ART) assay) was performed on 247 available samples taken at key decision time points during antiviral therapy of 105 genotype 1 patients (triple therapy: n = 70; dual therapy: n = 35).

Results

Overall concordance of HCV RNA measurements was high between the two Roche systems (89%; n = 220/247) but lower between the Roche assays and the ART (CAP/CTM Ver. 1 vs ART: 77.3%; n = 191/247 and CAP/CTM v.2 vs ART: 80.1%; n = 198/247). Most discrepancies were noted in week 4/8 samples with residual viremia (ConclusionAn abbreviated course of treatment can safely be applied in patients with residual viremia (

SUBMITTER: Strassl R 

PROVIDER: S-EPMC4537232 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy.

Strassl Robert R   Rutter Karoline K   Stättermayer Albert Friedrich AF   Beinhardt Sandra S   Kammer Michael M   Hofer Harald H   Ferenci Peter P   Popow-Kraupp Theresia T  

PloS one 20150814 8


<h4>Background and aims</h4>Monitoring of chronic Hepatitis C (CHC) treatment relies on HCV RNA quantification by means of real-time PCR methods. Assay specific analytical sensitivities may impact therapy management.<h4>Methods</h4>Comparative analysis between three commercial assays (Roche COBAS AmpliPrep/COBAS TaqMan Version 1 (CAP/CTM Ver. 1), Version 2 (CAP/CTM Ver. 2) and the Abbott RealTime HCV (ART) assay) was performed on 247 available samples taken at key decision time points during ant  ...[more]

Similar Datasets

| S-EPMC7108235 | biostudies-literature
| S-EPMC8476600 | biostudies-literature
| S-EPMC4411953 | biostudies-literature
| S-EPMC1287670 | biostudies-literature
| S-EPMC3591933 | biostudies-literature
| S-EPMC2268325 | biostudies-literature
| S-EPMC5361099 | biostudies-literature
| S-EPMC9628957 | biostudies-literature
| S-EPMC4118677 | biostudies-literature
| S-EPMC3994070 | biostudies-literature